INTRODUCTION
Periodontitis is considered as "an inflammatory disease of the supporting tissues of the teeth."
1 Chronic periodontitis is considered as the most common form of periodontitis, which is further classified as localized or generalized (more than 30% of the sites) depending on the site involvement. Various treatment modalities have been advocated in the treatment of periodontitis with an objective of maintenance of the natural dentition in a healthy state and allowing for proper function.
Presently, endogenous regenerative technology (ERT) has gained attention in the field of regeneration as it can trigger latent self-repair mechanisms in patients and activate the host's innate capacity for regeneration.
The most widely used ERT is PRF. The PRF, a secondgeneration platelet concentrate, 2 is an autologous leukocyte and PRF biomaterial as described by Choukroun. [3] [4] [5] It is made up of an integrated conclave of cytokines, glycanic chains, and structural glycoproteins encased within a slowly polymerized fibrin network. Currently, drugs have also been incorporated into ERT to create a material alcove in an injured site where the progenitor/stem cells from neighboring tissues can be employed for in situ periodontal regeneration. Metformin acts at a cellular level by reducing intracellular reactive oxygen species and apoptosis and exhibits a direct osteogenic effect on osteoblasts. The osteogenic effect is due to insulin-like growth factor-1 expression 6 and partially mediated via promotion of Runx2. Further, it can induce MC3T3E1 osteoblastic cell differentiation and bone matrix synthesis through adenosine 5′ monophosphate-activated protein kinase activation and subsequent induction of endothelial nitric oxide synthase and bone morphogenetic protein 2 expression. Hence, MTF is a drug of interest for the periodontist for treating periodontitis-induced alveolar bone loss.
The detection and accurate assessment of the location, extent, and configuration of the intrabony defect were done using CBCT as it is an enhanced tool to assess endosseous defect correctly.
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The present study is an effort to comparatively evaluate the efficacy of PRF with MTF and PRF alone in the treatment of intrabony periodontal defects both clinically and radiographically.
The study was conducted at the Department of Periodontology and Oral Implantology, Jaipur Dental College, Jaipur, Rajasthan, India. The proposed study began after the approval from the Institutional Research Review Board, Jaipur Dental College, Jaipur. Informed consent was taken from the subjects participating in the study.
MATERIALS AND METHODS
Subjects following a maintenance phase were recalled for periodontal assessment. A total of 20 subjects maintaining good oral hygiene with a minimum of two sites having vertical bony defects were selected. All subjects were randomly assigned to any one of the following groups using lottery system: Group I-OFD followed by placement of PRF with MTF 1% gel.
Group II-OFD followed by placement of PRF alone
Inclusion Criteria
Subjects in the age range of 35 to 55 years with systemically healthy status and pocket PD in the range of 5 to 7 mm, bilateral intrabony vertical defects, and radiographic evidence of vertical bone loss were included in the study.
Exclusion Criteria
Subjects with medically compromised status (history of diabetes, hypertension, thyroid), pregnant females or lactating mothers, subjects allergic to any type of medications, smokers, patient with unacceptable oral hygiene, and periodontal resurgical cases were excluded from the study.
Materials used in the Study
• Platelet-rich fibrin-A blood sample was taken without anticoagulant in 10 mL tubes, which were immediately centrifuged at 3,000 rpm (approximately 400g according to our calculations) for 10 minutes. This technique required neither anticoagulant nor bovine thrombin (nor any other gelling agent).
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• Metformin-A 1% MTF gel developed as dry gellan gum powder was dispersed in distilled water maintained at 95°C. The dispersion was stirred at 95°C for 20 minutes using a magnetic stirrer to facilitate hydration of gellan gum. The required amount of mannitol was added to the gellan gum solution with continuous stirring, and the temperature was maintained above 80°C. A weighed amount of MTF was added with stirring. Then sucralose, citric acid, and preservatives (methylparaben, propylparaben) were added with stirring. Finally, the required amount of sodium citrate was dissolved in 10 mL distilled water and added to the mixture. The mixture was allowed to cool to room temperature to form a gel.
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Storage and Shelf Life
The MTF gel was stored in a refrigerator at a temperature of 10 to 18°C and had a shelf life up to December 15, 2017.
In vitro Studies (Diffusion Cell)
The in vitro study part was carried out at Sree Dattha Institute of Pharmacy, Hyderabad, India.
Presurgical Phase
All subjects received scaling and root planing (SRP) followed by oral hygiene instructions. All patient underwent radiovisiography followed by CBCT for locating bony defects. Customized acrylic stent using cold-cure acrylic resins was prepared on the stone models by making alginate impressions of the subjects.
Clinical Parameters
All clinical parameters were recorded preoperatively (baseline recordings), at 6 and 9 months postoperatively. A stent was used along with a calibrated probe (UNC 15 probe) to ensure reliability and reproducibility of data collected sequentially. Clinical parameters recorded were plaque index, gingival index, PD, and RAL. Bone defect morphology was assessed using threedimensional (3D) CBCT (version 3.5.7; Carestream Health, Inc., New York, USA) with the following parameters: Slice thickness of 0.625 mm, exposure of 68 to 90 KVp, and 4 mA. It is a high-resolution CT scanner equipped with a 3D image reconstruction software (Carestream CS9300 imaging system imaging) For clinical procedure kindly refer (Figs 1 to 10 ).
Statistical Analysis
The data were coded and entered into a Microsoft Excel spreadsheet. Analysis was done using Statistical Package for the Social Sciences version 20 (IBM SPSS Statistics Inc., Chicago, Illinois, USA) Windows software program. The variables were assessed for normality using the Kolmogorov-Smirnov test. Descriptive statistics included computation of percentages, means, and standard deviations. 
RESULTS
Upon intragroup comparison for soft tissue parameters in group I (PRF + MTF), the mean values of plaque index
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and gingival index (Graphs 1 and 2) at 6 and 9 months from baseline were found to be nonsignificant. Comparison of change between 6 and 9 months revealed a nonsignificant change.
The mean values of PD and RAL (Graphs 3 and 4) at 6 and 9 months from baseline were found to be significant. Comparison of change between 6 and 9 months revealed a significant change.
In group II PRF, the mean values of plaque index at 6 and 9 months from baseline were found to be nonsignificant. Comparison of change between 6 and 9 months revealed a nonsignificant change. The mean values of gingival index at 6 and 9 months from baseline were found to be significant. Comparison of change between 6 and 9 months revealed a nonsignificant change.
The mean values of PD and RAL at 6 and 9 months from baseline were found to be significant. Comparison of change between 6 and 9 months revealed a nonsignificant change.
Considering hard tissue parameters in group I (PRF + MTF), the mean value of defect depth at 6 months from baseline was found to be nonsignificant and 9 months from baseline was found to be significant. Comparison of change between 6 and 9 months revealed a nonsignificant change.
The mean value of defect volume at 6 and 9 months from baseline was found to be significant. Comparison of change between 6 and 9 months revealed a significant change.
In group II PRF, the mean value of defect depth at (Graph 5) 6 months from baseline was found to be nonsignificant and at 9 months from baseline was found to be significant. Comparison of change between 6 and 9 months revealed a nonsignificant change. The mean value of defect volume (Graph 6) at 6 and 9 months from baseline was found to be significant. Comparison of change between 6 and 9 months revealed a significant change.
Upon intergroup comparison for mean plaque index scores, the mean difference from baseline to 6 months was nonsignificant. Mean difference from baseline to 9 months was found to be nonsignificant (Table 1) .
Mean gingival index score from baseline to 6 months was found to be nonsignificant in group I, while in group II it was found to be significant (p ≤ 0.05). Mean difference from baseline to 9 months was found to be nonsignificant in group I, while in group II, it was found to be significant (p ≤ 0.05) ( Table 2) .
Mean PD score from baseline to 6 months was found to be significant in all groups (p ≤ 0.05) ( Table 3) . Mean difference from baseline to 9 months was found to be significant in all groups (p ≤ 0.05).
Mean RAL score from baseline to 6 months was found to be significant in both the groups (p ≤ 0.05). Mean difference from baseline to 9 months was found to be significant in both the groups (p ≤ 0.05) ( Table 4) .
Mean defect depth score from baseline to 6 months was found to be significant in group I (p ≤ 0.05), while it was nonsignificant in group II. Mean difference from Graph 6: Mean defect volume at various time intervals of both the groups baseline to 9 months was found to be significant in both the groups (p ≤ 0.05) ( Table 5) . Mean defect volume score from baseline to 6 months was found to be significant in all groups (p ≤ 0.05). Mean difference from baseline to 9 months was found to be significant in both the groups (p ≤ 0.05) ( Table 6 ).
DISCUSSION
The present study was designed as a randomized controlled trial, which comprised 20 systemically healthy subjects having moderate-to-severe chronic generalized periodontitis with a minimum of two sites having intrabony defects (IBDs) totaling to 40 defect sites.
A comparative assessment of PRF with MTF and PRF alone in treatment of IBDs was done in the present study.
The clinical parameters assessed were plaque index; gingival index, PD, and RAL .
Plaque index and gingival index were recorded to assess the oral hygiene maintenance and inflammatory status at various time intervals. Probing depth and RAL were assessed to evaluate the outcome of various treatment modalities.
The CBCT was used for the study since it had various advantages over the conventional radiographic technique (intraoral periapical radiograph, orthopantomogram) such as display of multiple panoramic and cross-sectional images followed by generation in three types of views: Axial, cross-sectional, and panoramic.
The defects were randomly divided into two test groups using lottery method: Group I involved the use of PRF with MTF; group II involved the use of PRF only.
Presently, for periodontal regeneration, various chemical agents and growth factors have been advocated. The PRF has been used in different treatment modalities for root coverage and treating intrabony periodontal defects. Drugs, such as MTF had shown to have other beneficial properties besides their main properties, such as osteogenic potential. Hence, in the present study, it was incorporated in PRF to assess their regeneration potential.
In the present study, the role of MTF when incorporated with PRF was evaluated when placed in an IBD.
The MTF, a biguanide compound, is widely prescribed as the first-line antidiabetic agent for the treatment of type II diabetes mellitus as it is an insulin-sensitizing drug, lowering glycemic level without increasing insulin secretion. In the field of periodontology, it has been studied for its effect to reduce inflammatory cell infiltration and alveolar bone loss in periodontal tissue. It can be given either with a systemic administration or with local biodegradable sustained-release agents (gels, chips, membranes).
The MTF has been shown to promote osteoblastic differentiation and increase collagen synthesis as per studies done by Cortizo et al. 8 The study evaluated the effects of MTF on the growth and differentiation of osteoblasts in culture. The MTF also promoted osteoblastic differentiation: It increased type I collagen production in both cell lines and stimulated alkaline phosphatase activity in MC3T3E1 osteoblasts. who compared clinically and radiographically the efficacy of autologous PRF and autogenous bone graft obtained using bone scrapper in the treatment of intrabony periodontal defects and stated that although both gave similar results, using PRF is a safer, cheaper, less technique sensitive, and minimally invasive procedure.
CONCLUSION
The present study was an attempt to comparatively evaluate the regenerative potential of PRF with MTF and PRF alone in the treatment of intrabony periodontal defects.
Results showed an improvement in clinical parameters (plaque index, gingival index, PD, and RAL) as compared with baseline in both the groups. Statistically significant results were obtained in both the groups, with group I exhibiting higher statistically significant values as compared with group II.
Radiographically, there was significant reduction in defect depth and defect volume compared with baseline in both the groups, with group I exhibiting higher statistically significant values as compared with group II for defect depth reduction.
Both the treatment modalities (PRF + MTF and PRF alone) were found to be effective both clinically and radiographically in the treatment of IBDs.
However, the combination of PRF + MTF was proven to be better than PRF alone.
Further, long-term clinical trials with larger samples of various drug concentrations and longer durations should be carried out to assess a complete periodontal regeneration rather than bone regeneration.
